Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00EZO
|
||||
Former ID |
DIB012111
|
||||
Drug Name |
TC-2216
|
||||
Synonyms |
NNR Therapeutics; TC-5685; Nicotinic ACh modulators (schizophrenia), Targacept; Alpha-4 beta-2 neuronal nicotinic receptor (schizophrenia, depression), Targacept; Oral alpha-4/beta-2 neuronal nicotinic receptor stimulator (shizophrenia/depression), Targacept
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Mood disorder [ICD10:F30-F39] | Phase 1 | [522191] | ||
Company |
Targacept
|
||||
Structure |
Download2D MOL |
||||
Formula |
C12H17N3
|
||||
Canonical SMILES |
N1(CC2(NCCC2)CC1)c1cnccc1
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Nicotinic ACh receptor alpha 4/beta 2 | Target Info | Modulator | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.